News

As per the terms of the agreement, AgaMatrix and sanofi-aventis are expected to co-develop solutions in diabetes management that incorporate AgaMatrix’s WaveSense technology. AgaMatrix’s proprietary WaveSense technology personalizes

Duodart is indicated in the treatment of moderate-to-severe symptoms of benign prostatic hyperplasia (BPH) and reduction in the risk of acute urinary retention (AUR) and surgery in patients

BioNanomatrix has also disclosed the methods of preparing nanochannel array chips, methods of analyzing macromolecules such as entire strands of genomic DNA, and systems for implementing these methods.

AdvanDx said that the faster protocol reduces PNA Fish turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to

AFFiRiS said that the vaccine has undergone numerous preclinical tests which have confirmed its principle of action (Proof of Concept). The company is now starting to prepare for

The waiver is the monitoring technology that can be used in a broader range of clinical settings, such as labs that do not meet the requirements to do

The purpose of MOU is to continue to develop and expand a framework of cooperation between BBDC and Igen to implement a mutually beneficial program, whereby Igen will

In addition to treating burns and other acute wounds, ReCell will also target the growing demand for aesthetic surgery, scar revision and dermal treatments for the aging population.

Earlier, in September 2009, the World Health Organisation has entered into two sublicences, under its Global Pandemic Influenza Action Plan for developing countries, with the Government Pharmaceutical Organisation